drugset / Trial / NCT02195947

Antagonist Protocol in Poor Responders

NCT02195947

Phase 4 Completed 141 enrolled Cairo University
RandomizedParallel-groupOpen-labelTreatment

Summary

The effect of use of the growth hormone with antagonist protocol on the outcome of the IVF/ICSI cycles in poor responders.

Timeline

Start
2014-07
Primary completion
2015-07
Completion
2015-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Somatropin Protein / enzyme biologic 2.5 mg Subcutaneous

Indications